Viridans-Group Streptococci: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*A [[Gram Positive Bacteria]] in the [[Streptococcus Genus]] | *A [[Gram Positive Bacteria]] in the [[Streptococcus Genus]] | ||
*In general, low virulence pathogens and likely [[Blood Culture Contaminant]] (21-50% of positive blood cultures are clinically significant | *In general, low virulence pathogens and likely [[Blood Culture Contaminant]] unless risk factor (21-50% of positive blood cultures are clinically significant)<ref>Antibiotic Therapy for Positive Blood Cultures. Perez-Jorge EV, et al. Antimicrobe. http://www.antimicrobe.org/new/e38rev2.asp</ref> | ||
==Types== | ==Types== | ||
| Line 17: | Line 17: | ||
*high dose chemotherapy | *high dose chemotherapy | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|''' | | align="center" style="background:#f0f0f0;"|'''Category''' | ||
| align="center" style="background:#f0f0f0;"|'''''' | | align="center" style="background:#f0f0f0;"|'''Antibiotic''' | ||
| align="center" style="background:#f0f0f0;"|'''Viridans strep''' | | align="center" style="background:#f0f0f0;"|'''[[Viridans strep]]''' | ||
|- | |- | ||
| Penicillins||Penicillin G|| | | [[Penicillins]]||[[Penicillin G]]||I | ||
|- | |- | ||
| ||Penicillin V|| | | ||[[Penicillin V]]||I | ||
|- | |- | ||
| | | ||[[Methicillin]]||I | ||
|- | |- | ||
| ||Nafcillin/Oxacillin|| | | ||[[Nafcillin]]/[[Oxacillin]]||I | ||
|- | |- | ||
| ||Cloxacillin/Diclox.|| | | ||[[Cloxacillin]]/[[Diclox.]]||I | ||
|- | |- | ||
| Amino-Penicillins||AMP/Amox|| | | Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||I | ||
|- | |- | ||
| ||Amox | | ||[[Amox-Clav]]||I | ||
|- | |- | ||
| ||AMP-Sulb|| | | ||[[AMP-Sulb]]||I | ||
|- | |- | ||
| Anti-Pseudomonal Penicillins||Ticarcillin|| | | Anti-Pseudomonal [[Penicillins]]||[[Ticarcillin]]||I | ||
|- | |- | ||
| ||Ticar-Clav|| | | ||[[Ticar-Clav]]||I | ||
|- | |- | ||
| ||Pip- | | ||[[Pip-Tazo]]||I | ||
|- | |- | ||
| | | ||Piperacillin||I | ||
|- | |- | ||
| ||Doripenem|| | | [[Carbapenems]]||Doripenem||S | ||
|- | |- | ||
| ||Ertapenem|| | | ||[[Ertapenem]]||S | ||
|- | |- | ||
| ||Imipenem|| | | ||[[Imipenem]]||S | ||
|- | |- | ||
| ||Meropenem|| | | ||[[Meropenem]]||S | ||
|- | |- | ||
| ||[[Aztreonam]]|| | | ||[[Aztreonam]]||R | ||
|- | |- | ||
| [[Fluroquinolones]]||[[Ciprofloxacin]]|| | | [[Fluroquinolones]]||[[Ciprofloxacin]]||R | ||
|- | |- | ||
| ||Ofloxacin|| | | ||[[Ofloxacin]]||R | ||
|- | |- | ||
| ||Pefloxacin|| | | ||Pefloxacin||X1 | ||
|- | |- | ||
| ||[[Levofloxacin]]|| | | ||[[Levofloxacin]]||S | ||
|- | |- | ||
| ||Moxifloxacin|| | | ||[[Moxifloxacin]]||S | ||
|- | |- | ||
| ||Gemifloxacin|| | | ||Gemifloxacin||S | ||
|- | |- | ||
| ||Gatifloxacin|| | | ||Gatifloxacin||S | ||
|- | |- | ||
| 1st G [[ | | 1st G [[Cephalo]]||Cefazolin||S | ||
|- | |- | ||
| 2nd G. | | 2nd G. [[Cephalo]]||[[Cefotetan]]||S | ||
|- | |- | ||
| ||Cefoxitin|| | | ||[[Cefoxitin]]||S | ||
|- | |- | ||
| ||Cefuroxime|| | | ||[[Cefuroxime]]||S | ||
|- | |- | ||
| 3rd/4th G. | | 3rd/4th G. [[Cephalo]]||[[Cefotaxime]]||S | ||
|- | |- | ||
| ||Cefizoxime|| | | ||Cefizoxime||S | ||
|- | |- | ||
| ||[[CefTRIAXone]]|| | | ||[[CefTRIAXone]]||S | ||
|- | |- | ||
| || | | ||Ceftaroline||S | ||
|- | |- | ||
| || | | ||[[CefTAZidime]]||I | ||
|- | |- | ||
| ||[[ | | ||[[Cefepime]]||S | ||
|- | |- | ||
| | | Oral 1st G. [[Cephalo]]||Cefadroxil||S | ||
|- | |- | ||
| | | ||[[Cephalexin]]||S | ||
|- | |- | ||
| | | Oral 2nd G. [[Cephalo]]||Cefaclor/Loracarbef||S | ||
|- | |- | ||
| | | ||Cefproxil||R | ||
|- | |- | ||
| || | | ||Cefuroxime axetil||S | ||
|- | |- | ||
| || | | Oral 3rd G. [[Cephalo]]||Cefixime||S | ||
|- | |- | ||
| | | ||Ceftibuten||R | ||
|- | |- | ||
| || | | ||Cefpodox/Cefdinir/Cefditoren||S | ||
|- | |- | ||
| || | | [[Aminoglycosides]]||[[Gentamicin]]||X1 | ||
|- | |- | ||
| | | ||Tobramycin||X1 | ||
|- | |- | ||
| || | | ||[[Amikacin]]||X1 | ||
|- | |- | ||
| ||[[ | | ||[[Chloramphenicol]]||X1 | ||
|- | |- | ||
| || | | ||[[Clindamycin]]||X1 | ||
|- | |- | ||
| [[Macrolides]]||Erythromycin||X1 | |||
|- | |- | ||
| [[ | | ||[[Azithromycin]]||X1 | ||
|- | |- | ||
| || | | ||Clarithromycin||X1 | ||
|- | |- | ||
| || | | Ketolide||Telithromycin||X1 | ||
|- | |- | ||
| | | Tetracyclines||[[Doxycycline]]||X1 | ||
|- | |- | ||
| | | ||Minocycline||X1 | ||
|- | |- | ||
| || | | Glycylcycline||Tigecycline||X1 | ||
|- | |- | ||
| | | ||Daptomycin||X1 | ||
|- | |- | ||
| Glyco/Lipoclycopeptides||[[Vancomycin]]|| | | Glyco/Lipoclycopeptides||[[Vancomycin]]||X1 | ||
|- | |- | ||
| ||Teicoplanin|| | | ||Teicoplanin||X1 | ||
|- | |- | ||
| ||Telavancin|| | | ||Telavancin||X1 | ||
|- | |- | ||
| ||Fusidic Acid|| | | ||Fusidic Acid||X1 | ||
|- | |- | ||
| ||Trimethoprim|| | | ||Trimethoprim||X1 | ||
|- | |- | ||
| ||[[TMP-SMX]]|| | | ||[[TMP-SMX]]||X1 | ||
|- | |- | ||
| Urinary Agents||[[Nitrofurantoin]]|| | | Urinary Agents||[[Nitrofurantoin]]||X1 | ||
|- | |- | ||
| ||Fosfomycin|| | | ||Fosfomycin||X1 | ||
|- | |- | ||
| Other||[[Rifampin]]|| | | Other||[[Rifampin]]||X1 | ||
|- | |- | ||
| ||[[Metronidazole]]|| | | ||[[Metronidazole]]||X1 | ||
|- | |- | ||
| ||Quinupristin dalfoppristin|| | | ||Quinupristin dalfoppristin||X1 | ||
|- | |- | ||
| ||Linezolid|| | | ||[[Linezolid]]||X1 | ||
|- | |- | ||
| ||Colistimethate||X1 | |||
| ||Colistimethate|| | |||
|} | |} | ||
===Key=== | ===Key=== | ||
{{Template:Antibacterial Spectra Key}} | {{Template:Antibacterial Spectra Key}} | ||
Latest revision as of 06:30, 3 June 2014
Background
- A Gram Positive Bacteria in the Streptococcus Genus
- In general, low virulence pathogens and likely Blood Culture Contaminant unless risk factor (21-50% of positive blood cultures are clinically significant)[1]
Types
- Streptococcus milleri
- Streptococcus sanguis
- Streptococcus mitis
- Streptococcus bovis
Risk Factors for Viridans Bacteremia[2]
- neutropenia
- oral mucositis
- irradiation to the oral cavity
- antibiotic prophylaxis with trimethoprim-sulfamethoxazole or fluoroquinolones
- intravenous hyperalimentation
- high dose chemotherapy
Antibiotic Sensitivities[3]
| Category | Antibiotic | Viridans strep |
| Penicillins | Penicillin G | I |
| Penicillin V | I | |
| Methicillin | I | |
| Nafcillin/Oxacillin | I | |
| Cloxacillin/Diclox. | I | |
| Amino-Penicillins | AMP/Amox | I |
| Amox-Clav | I | |
| AMP-Sulb | I | |
| Anti-Pseudomonal Penicillins | Ticarcillin | I |
| Ticar-Clav | I | |
| Pip-Tazo | I | |
| Piperacillin | I | |
| Carbapenems | Doripenem | S |
| Ertapenem | S | |
| Imipenem | S | |
| Meropenem | S | |
| Aztreonam | R | |
| Fluroquinolones | Ciprofloxacin | R |
| Ofloxacin | R | |
| Pefloxacin | X1 | |
| Levofloxacin | S | |
| Moxifloxacin | S | |
| Gemifloxacin | S | |
| Gatifloxacin | S | |
| 1st G Cephalo | Cefazolin | S |
| 2nd G. Cephalo | Cefotetan | S |
| Cefoxitin | S | |
| Cefuroxime | S | |
| 3rd/4th G. Cephalo | Cefotaxime | S |
| Cefizoxime | S | |
| CefTRIAXone | S | |
| Ceftaroline | S | |
| CefTAZidime | I | |
| Cefepime | S | |
| Oral 1st G. Cephalo | Cefadroxil | S |
| Cephalexin | S | |
| Oral 2nd G. Cephalo | Cefaclor/Loracarbef | S |
| Cefproxil | R | |
| Cefuroxime axetil | S | |
| Oral 3rd G. Cephalo | Cefixime | S |
| Ceftibuten | R | |
| Cefpodox/Cefdinir/Cefditoren | S | |
| Aminoglycosides | Gentamicin | X1 |
| Tobramycin | X1 | |
| Amikacin | X1 | |
| Chloramphenicol | X1 | |
| Clindamycin | X1 | |
| Macrolides | Erythromycin | X1 |
| Azithromycin | X1 | |
| Clarithromycin | X1 | |
| Ketolide | Telithromycin | X1 |
| Tetracyclines | Doxycycline | X1 |
| Minocycline | X1 | |
| Glycylcycline | Tigecycline | X1 |
| Daptomycin | X1 | |
| Glyco/Lipoclycopeptides | Vancomycin | X1 |
| Teicoplanin | X1 | |
| Telavancin | X1 | |
| Fusidic Acid | X1 | |
| Trimethoprim | X1 | |
| TMP-SMX | X1 | |
| Urinary Agents | Nitrofurantoin | X1 |
| Fosfomycin | X1 | |
| Other | Rifampin | X1 |
| Metronidazole | X1 | |
| Quinupristin dalfoppristin | X1 | |
| Linezolid | X1 | |
| Colistimethate | X1 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Antibiotic Therapy for Positive Blood Cultures. Perez-Jorge EV, et al. Antimicrobe. http://www.antimicrobe.org/new/e38rev2.asp
- ↑ Antibiotic Therapy for Positive Blood Cultures. Perez-Jorge EV, et al. Antimicrobe. http://www.antimicrobe.org/new/e38rev2.asp
- ↑ Sanford Guide to Antimicrobial Therapy 2014
